Clinical trial · Observational
Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy
Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy: Development of a Decision Aid Tool
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to develop test and evaluate a Patient Decision Aid called "The Decision Helper" among melanoma patients eligible for adjuvant treatment. * Is the Decision Helper an acceptable tool for patients and clinicians and is it feasible in clinical practice? * Are there any differences in the levels of decisional regret in the patients who have not used the Decision Helper (pre-implementation) compared to the ones who have (post-implementation?
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Melanoma | Melanoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Development of a Patient Decision Aid "The Decision Helper" for melanoma patients receiving adjuvant theory
- timeFrame
- 1 year
- description
- To develop a Patient Decision Aid for melanoma patients receiving adjuvant theory
- measure
- Evaluation of the "The Decision Helper"
- timeFrame
- 1 year
- description
- To evaluate "The Decision Helper among patients and healthcare professionals"
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Danish speaking * Diagnosed with stage 3 malignant melanoma * Eligible for adjuvant immunotherapy Exclusion Criteria: * Metastatic disease * Mental impairment
References
Publications (0)
Data not yet available